Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, June 5, 2026

EEG biomarkers for assessment, prognosis, and monitoring of natural upper limb recovery after stroke: a systematic review

 'Assessments' DO NOTHING FOR RECOVERY! You need EXACT REHAB PROTOCOLS FOR THAT! And you're too fucking incompetent to figure that out? You're all fired!

Biomarkers do nothing for recovery unless you are mapping EXACT RECOVERY PROTOCOLS to them!

EEG biomarkers for assessment, prognosis, and monitoring of natural upper limb recovery after stroke: a systematic review

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Abstract

Background

Persistent upper limb deficits after stroke necessitate reliable candidate biomarkers to support precision rehabilitation. While electroencephalogram (EEG) provides a highly accessible tool to characterize post-stroke neurophysiology, its clinical translation is hindered by fragmented evidence. This systematical review critically synthesizes the directional associations between EEG biomarkers and upper limb outcomes, and introduces a novel functional framework to classify these biomarkers into assessment, prognostic, and monitoring roles for natural upper limb recovery under conventional rehabilitation.

Methods

A systematic search was conducted in MEDLINE, SCOPUS, EMBASE, EBSCO CINAHL, and IEEE Xplore up to March 10, 2026. Studies investigating associations between quantitative EEG measures and upper limb motor outcomes in stroke adults were included. Two reviewers independently screened studies and assessed risk of bias. Data extraction classified EEG biomarkers by assessment, prognosis, and monitoring roles.

Results

Forty-two studies were included, comprising 23 cross-sectional and 19 longitudinal designs. We categorized the evidence into three biomarker roles: (i) assessment, where measures like the brain symmetry index (BSI), β-band interhemispheric connectivity, and network efficiency correlated with impairment severity; (ii) prognostic, where baseline asymmetry and functional connectivity showed predictive potential; and (iii) monitoring, where longitudinal changes in oscillatory power, connectivity, and network topology paralleled functional gains. Across roles, the BSI emerged as one of the most frequently reported candidate metrics.

Conclusion

EEG-derived metrics, particularly the BSI, serve as frequently reported candidate biomarkers for potential clinical application in stroke rehabilitation. However, their immediate clinical translation is currently limited by the predominantly fair methodological quality of the underlying evidence. Our proposed framework helps to bridge the gap between current observational findings and future clinical utility. Future progress hinges on standardizing protocols and validating these biomarkers in large-scale rehabilitation trials to facilitate their transition toward potentially clinically useful tools.

No comments:

Post a Comment